世界の慢性期マーカー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chronic Phase Marker Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4016
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、慢性期マーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍マーカー、心筋梗塞マーカー、甲状腺マーカー、その他）、用途別市場規模（病院、診療所、診断研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・慢性期マーカーの市場動向
・企業の競争状況、市場シェア
・慢性期マーカーの種類別市場規模と予測2016-2027（腫瘍マーカー、心筋梗塞マーカー、甲状腺マーカー、その他）
・慢性期マーカーの用途別市場規模と予測2016-2027（病院、診療所、診断研究所）
・慢性期マーカーの北米市場規模2016-2027（アメリカ、カナダ）
・慢性期マーカーの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・慢性期マーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・慢性期マーカーの中南米市場規模2016-2027（メキシコ、ブラジル）
・慢性期マーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Nordic BioSite、DiaSorin、Roche、Bristol-Myers Squibb、Hologic、QIAGEN、Philips、Johnson & Johnson、Lifesign、Natus、BrainScope）
・結論

Markers are broadly categorized as biomarkers or molecular markers and biochemical markers. Biomarker, also known as biological marker is commonly used to carry out detection of living organism which acts as a causative agent for specific diseases. It usually refers to a measurable indicator for various biological states or disease conditions in the human body. Biomarker is any substance that can be utilized as an indicator of specific disease condition and is often evaluated to detect pathogenic processes, normal biological process, or pharmacologic response to medical treatment. The elevated levels or absence of these biological markers may indicate the onset or late stage of a chronic disease. However, chronic phase indicates early stages of chronic leukemia which is a type of cancer in white blood cells. It constitutes high amounts of abnormal white blood cells in bone marrow and blood. Chronic phase markers are the biomarkers that help in detection of a disease condition with the presence of their elevated levels in patient’s body.

Market Analysis and Insights: Global Chronic Phase Marker Market
The global Chronic Phase Marker market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Phase Marker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Phase Marker market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Phase Marker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Phase Marker market.

Global Chronic Phase Marker Scope and Market Size
Chronic Phase Marker market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Phase Marker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tumor Markers
Cardiac Markers
Thyroid Markers
Others

Segment by Application
Hospitals
Clinics
Diagnostic Laboratories

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Nordic BioSite
DiaSorin
Roche
Bristol-Myers Squibb
Hologic
QIAGEN
Philips
Johnson & Johnson
Lifesign
Natus
BrainScope

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Phase Marker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tumor Markers
1.2.3 Cardiac Markers
1.2.4 Thyroid Markers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chronic Phase Marker Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chronic Phase Marker Market Perspective (2016-2027)
2.2 Chronic Phase Marker Growth Trends by Regions
2.2.1 Chronic Phase Marker Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Phase Marker Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Phase Marker Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Phase Marker Industry Dynamic
2.3.1 Chronic Phase Marker Market Trends
2.3.2 Chronic Phase Marker Market Drivers
2.3.3 Chronic Phase Marker Market Challenges
2.3.4 Chronic Phase Marker Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chronic Phase Marker Players by Revenue
3.1.1 Global Top Chronic Phase Marker Players by Revenue (2016-2021)
3.1.2 Global Chronic Phase Marker Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Phase Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Phase Marker Revenue
3.4 Global Chronic Phase Marker Market Concentration Ratio
3.4.1 Global Chronic Phase Marker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Phase Marker Revenue in 2020
3.5 Chronic Phase Marker Key Players Head office and Area Served
3.6 Key Players Chronic Phase Marker Product Solution and Service
3.7 Date of Enter into Chronic Phase Marker Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Phase Marker Breakdown Data by Type
4.1 Global Chronic Phase Marker Historic Market Size by Type (2016-2021)
4.2 Global Chronic Phase Marker Forecasted Market Size by Type (2022-2027)

5 Chronic Phase Marker Breakdown Data by Application
5.1 Global Chronic Phase Marker Historic Market Size by Application (2016-2021)
5.2 Global Chronic Phase Marker Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chronic Phase Marker Market Size (2016-2027)
6.2 North America Chronic Phase Marker Market Size by Type
6.2.1 North America Chronic Phase Marker Market Size by Type (2016-2021)
6.2.2 North America Chronic Phase Marker Market Size by Type (2022-2027)
6.2.3 North America Chronic Phase Marker Market Size by Type (2016-2027)
6.3 North America Chronic Phase Marker Market Size by Application
6.3.1 North America Chronic Phase Marker Market Size by Application (2016-2021)
6.3.2 North America Chronic Phase Marker Market Size by Application (2022-2027)
6.3.3 North America Chronic Phase Marker Market Size by Application (2016-2027)
6.4 North America Chronic Phase Marker Market Size by Country
6.4.1 North America Chronic Phase Marker Market Size by Country (2016-2021)
6.4.2 North America Chronic Phase Marker Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Chronic Phase Marker Market Size (2016-2027)
7.2 Europe Chronic Phase Marker Market Size by Type
7.2.1 Europe Chronic Phase Marker Market Size by Type (2016-2021)
7.2.2 Europe Chronic Phase Marker Market Size by Type (2022-2027)
7.2.3 Europe Chronic Phase Marker Market Size by Type (2016-2027)
7.3 Europe Chronic Phase Marker Market Size by Application
7.3.1 Europe Chronic Phase Marker Market Size by Application (2016-2021)
7.3.2 Europe Chronic Phase Marker Market Size by Application (2022-2027)
7.3.3 Europe Chronic Phase Marker Market Size by Application (2016-2027)
7.4 Europe Chronic Phase Marker Market Size by Country
7.4.1 Europe Chronic Phase Marker Market Size by Country (2016-2021)
7.4.2 Europe Chronic Phase Marker Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chronic Phase Marker Market Size (2016-2027)
8.2 Asia-Pacific Chronic Phase Marker Market Size by Type
8.2.1 Asia-Pacific Chronic Phase Marker Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Phase Marker Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Phase Marker Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Phase Marker Market Size by Application
8.3.1 Asia-Pacific Chronic Phase Marker Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Phase Marker Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Phase Marker Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Phase Marker Market Size by Region
8.4.1 Asia-Pacific Chronic Phase Marker Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Phase Marker Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chronic Phase Marker Market Size (2016-2027)
9.2 Latin America Chronic Phase Marker Market Size by Type
9.2.1 Latin America Chronic Phase Marker Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Phase Marker Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Phase Marker Market Size by Type (2016-2027)
9.3 Latin America Chronic Phase Marker Market Size by Application
9.3.1 Latin America Chronic Phase Marker Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Phase Marker Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Phase Marker Market Size by Application (2016-2027)
9.4 Latin America Chronic Phase Marker Market Size by Country
9.4.1 Latin America Chronic Phase Marker Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Phase Marker Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chronic Phase Marker Market Size (2016-2027)
10.2 Middle East & Africa Chronic Phase Marker Market Size by Type
10.2.1 Middle East & Africa Chronic Phase Marker Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Phase Marker Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Phase Marker Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Phase Marker Market Size by Application
10.3.1 Middle East & Africa Chronic Phase Marker Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Phase Marker Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Phase Marker Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Phase Marker Market Size by Country
10.4.1 Middle East & Africa Chronic Phase Marker Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Phase Marker Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Nordic BioSite
11.1.1 Nordic BioSite Company Details
11.1.2 Nordic BioSite Business Overview
11.1.3 Nordic BioSite Chronic Phase Marker Introduction
11.1.4 Nordic BioSite Revenue in Chronic Phase Marker Business (2016-2021)
11.1.5 Nordic BioSite Recent Development
11.2 DiaSorin
11.2.1 DiaSorin Company Details
11.2.2 DiaSorin Business Overview
11.2.3 DiaSorin Chronic Phase Marker Introduction
11.2.4 DiaSorin Revenue in Chronic Phase Marker Business (2016-2021)
11.2.5 DiaSorin Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Chronic Phase Marker Introduction
11.3.4 Roche Revenue in Chronic Phase Marker Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Chronic Phase Marker Introduction
11.4.4 Bristol-Myers Squibb Revenue in Chronic Phase Marker Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Hologic
11.5.1 Hologic Company Details
11.5.2 Hologic Business Overview
11.5.3 Hologic Chronic Phase Marker Introduction
11.5.4 Hologic Revenue in Chronic Phase Marker Business (2016-2021)
11.5.5 Hologic Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Details
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Chronic Phase Marker Introduction
11.6.4 QIAGEN Revenue in Chronic Phase Marker Business (2016-2021)
11.6.5 QIAGEN Recent Development
11.7 Philips
11.7.1 Philips Company Details
11.7.2 Philips Business Overview
11.7.3 Philips Chronic Phase Marker Introduction
11.7.4 Philips Revenue in Chronic Phase Marker Business (2016-2021)
11.7.5 Philips Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Chronic Phase Marker Introduction
11.8.4 Johnson & Johnson Revenue in Chronic Phase Marker Business (2016-2021)
11.8.5 Johnson & Johnson Recent Development
11.9 Lifesign
11.9.1 Lifesign Company Details
11.9.2 Lifesign Business Overview
11.9.3 Lifesign Chronic Phase Marker Introduction
11.9.4 Lifesign Revenue in Chronic Phase Marker Business (2016-2021)
11.9.5 Lifesign Recent Development
11.10 Natus
11.10.1 Natus Company Details
11.10.2 Natus Business Overview
11.10.3 Natus Chronic Phase Marker Introduction
11.10.4 Natus Revenue in Chronic Phase Marker Business (2016-2021)
11.10.5 Natus Recent Development
11.11 BrainScope
11.11.1 BrainScope Company Details
11.11.2 BrainScope Business Overview
11.11.3 BrainScope Chronic Phase Marker Introduction
11.11.4 BrainScope Revenue in Chronic Phase Marker Business (2016-2021)
11.11.5 BrainScope Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chronic Phase Marker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tumor Markers
Table 3. Key Players of Cardiac Markers
Table 4. Key Players of Thyroid Markers
Table 5. Key Players of Others
Table 6. Global Chronic Phase Marker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chronic Phase Marker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Chronic Phase Marker Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Chronic Phase Marker Market Share by Regions (2016-2021)
Table 10. Global Chronic Phase Marker Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Chronic Phase Marker Market Share by Regions (2022-2027)
Table 12. Chronic Phase Marker Market Trends
Table 13. Chronic Phase Marker Market Drivers
Table 14. Chronic Phase Marker Market Challenges
Table 15. Chronic Phase Marker Market Restraints
Table 16. Global Chronic Phase Marker Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Chronic Phase Marker Market Share by Players (2016-2021)
Table 18. Global Top Chronic Phase Marker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Phase Marker as of 2020)
Table 19. Ranking of Global Top Chronic Phase Marker Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Chronic Phase Marker Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chronic Phase Marker Product Solution and Service
Table 23. Date of Enter into Chronic Phase Marker Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Phase Marker Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Chronic Phase Marker Revenue Market Share by Type (2016-2021)
Table 27. Global Chronic Phase Marker Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Chronic Phase Marker Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Chronic Phase Marker Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Chronic Phase Marker Revenue Market Share by Application (2016-2021)
Table 31. Global Chronic Phase Marker Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Chronic Phase Marker Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Chronic Phase Marker Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Chronic Phase Marker Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Chronic Phase Marker Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Chronic Phase Marker Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Chronic Phase Marker Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Chronic Phase Marker Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Chronic Phase Marker Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Chronic Phase Marker Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Chronic Phase Marker Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Chronic Phase Marker Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Chronic Phase Marker Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Chronic Phase Marker Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chronic Phase Marker Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chronic Phase Marker Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chronic Phase Marker Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Chronic Phase Marker Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Chronic Phase Marker Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Chronic Phase Marker Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Chronic Phase Marker Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Chronic Phase Marker Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Chronic Phase Marker Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Chronic Phase Marker Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Chronic Phase Marker Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Chronic Phase Marker Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chronic Phase Marker Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chronic Phase Marker Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chronic Phase Marker Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Chronic Phase Marker Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Chronic Phase Marker Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Chronic Phase Marker Market Size by Country (2022-2027) & (US$ Million)
Table 63. Nordic BioSite Company Details
Table 64. Nordic BioSite Business Overview
Table 65. Nordic BioSite Chronic Phase Marker Product
Table 66. Nordic BioSite Revenue in Chronic Phase Marker Business (2016-2021) & (US$ Million)
Table 67. Nordic BioSite Recent Development
Table 68. DiaSorin Company Details
Table 69. DiaSorin Business Overview
Table 70. DiaSorin Chronic Phase Marker Product
Table 71. DiaSorin Revenue in Chronic Phase Marker Business (2016-2021) & (US$ Million)
Table 72. DiaSorin Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Chronic Phase Marker Product
Table 76. Roche Revenue in Chronic Phase Marker Business (2016-2021) & (US$ Million)
Table 77. Roche Recent Development
Table 78. Bristol-Myers Squibb Company Details
Table 79. Bristol-Myers Squibb Business Overview
Table 80. Bristol-Myers Squibb Chronic Phase Marker Product
Table 81. Bristol-Myers Squibb Revenue in Chronic Phase Marker Business (2016-2021) & (US$ Million)
Table 82. Bristol-Myers Squibb Recent Development
Table 83. Hologic Company Details
Table 84. Hologic Business Overview
Table 85. Hologic Chronic Phase Marker Product
Table 86. Hologic Revenue in Chronic Phase Marker Business (2016-2021) & (US$ Million)
Table 87. Hologic Recent Development
Table 88. QIAGEN Company Details
Table 89. QIAGEN Business Overview
Table 90. QIAGEN Chronic Phase Marker Product
Table 91. QIAGEN Revenue in Chronic Phase Marker Business (2016-2021) & (US$ Million)
Table 92. QIAGEN Recent Development
Table 93. Philips Company Details
Table 94. Philips Business Overview
Table 95. Philips Chronic Phase Marker Product
Table 96. Philips Revenue in Chronic Phase Marker Business (2016-2021) & (US$ Million)
Table 97. Philips Recent Development
Table 98. Johnson & Johnson Company Details
Table 99. Johnson & Johnson Business Overview
Table 100. Johnson & Johnson Revenue in Chronic Phase Marker Business (2016-2021) & (US$ Million)
Table 101. Johnson & Johnson Recent Development
Table 102. Lifesign Company Details
Table 103. Lifesign Business Overview
Table 104. Lifesign Chronic Phase Marker Product
Table 105. Lifesign Revenue in Chronic Phase Marker Business (2016-2021) & (US$ Million)
Table 106. Lifesign Recent Development
Table 107. Natus Company Details
Table 108. Natus Business Overview
Table 109. Natus Chronic Phase Marker Product
Table 110. Natus Revenue in Chronic Phase Marker Business (2016-2021) & (US$ Million)
Table 111. Natus Recent Development
Table 112. BrainScope Company Details
Table 113. BrainScope Business Overview
Table 114. BrainScope Chronic Phase Marker Product
Table 115. BrainScope Revenue in Chronic Phase Marker Business (2016-2021) & (US$ Million)
Table 116. BrainScope Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Phase Marker Market Share by Type: 2020 VS 2027
Figure 2. Tumor Markers Features
Figure 3. Cardiac Markers Features
Figure 4. Thyroid Markers Features
Figure 5. Others Features
Figure 6. Global Chronic Phase Marker Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Chronic Phase Marker Report Years Considered
Figure 11. Global Chronic Phase Marker Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Chronic Phase Marker Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Chronic Phase Marker Market Share by Regions: 2020 VS 2027
Figure 14. Global Chronic Phase Marker Market Share by Regions (2022-2027)
Figure 15. Global Chronic Phase Marker Market Share by Players in 2020
Figure 16. Global Top Chronic Phase Marker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Phase Marker as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Chronic Phase Marker Revenue in 2020
Figure 18. Global Chronic Phase Marker Revenue Market Share by Type (2016-2021)
Figure 19. Global Chronic Phase Marker Revenue Market Share by Type (2022-2027)
Figure 20. North America Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Chronic Phase Marker Market Share by Type (2016-2027)
Figure 22. North America Chronic Phase Marker Market Share by Application (2016-2027)
Figure 23. North America Chronic Phase Marker Market Share by Country (2016-2027)
Figure 24. United States Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Chronic Phase Marker Market Share by Type (2016-2027)
Figure 28. Europe Chronic Phase Marker Market Share by Application (2016-2027)
Figure 29. Europe Chronic Phase Marker Market Share by Country (2016-2027)
Figure 30. Germany Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Chronic Phase Marker Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Chronic Phase Marker Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Chronic Phase Marker Market Share by Region (2016-2027)
Figure 40. China Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Chronic Phase Marker Market Share by Type (2016-2027)
Figure 48. Latin America Chronic Phase Marker Market Share by Application (2016-2027)
Figure 49. Latin America Chronic Phase Marker Market Share by Country (2016-2027)
Figure 50. Mexico Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Chronic Phase Marker Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Chronic Phase Marker Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Chronic Phase Marker Market Share by Country (2016-2027)
Figure 56. Turkey Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Chronic Phase Marker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Nordic BioSite Revenue Growth Rate in Chronic Phase Marker Business (2016-2021)
Figure 60. DiaSorin Revenue Growth Rate in Chronic Phase Marker Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Chronic Phase Marker Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Chronic Phase Marker Business (2016-2021)
Figure 63. Hologic Revenue Growth Rate in Chronic Phase Marker Business (2016-2021)
Figure 64. QIAGEN Revenue Growth Rate in Chronic Phase Marker Business (2016-2021)
Figure 65. Philips Revenue Growth Rate in Chronic Phase Marker Business (2016-2021)
Figure 66. Johnson & Johnson Revenue Growth Rate in Chronic Phase Marker Business (2016-2021)
Figure 67. Lifesign Revenue Growth Rate in Chronic Phase Marker Business (2016-2021)
Figure 68. Natus Revenue Growth Rate in Chronic Phase Marker Business (2016-2021)
Figure 69. BrainScope Revenue Growth Rate in Chronic Phase Marker Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の慢性歯肉口内炎治療市場規模・現状・予測（2021年-2027年）

Global Chronic Gingivostomatitis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5660 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、慢性歯肉口内炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、抗ウイルス薬、抗菌薬、その他）、用途別市場規模（病院＆診療所、大学＆研究機関、その他）、主要地域別市場規模（北...

世界の慢性創傷ケア市場規模・現状・予測（2021年-2027年）

Global Chronic Wound Care Market Size, Status and Forecast 2021-2027
QFJ1-4019 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、慢性創傷ケアの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（創傷被覆材、生物学的製剤、治療装置、その他）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界の非ホジキンリンパ腫＆慢性リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4588 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、非ホジキンリンパ腫＆慢性リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（B細胞、T細胞）、用途別市場規模（化学療法、免疫療法、標的療法、放射線療法、幹細胞移植）、主要地域別市場規模（北米、...

世界の慢性骨髄性白血病（CML）治療市場規模・現状・予測（2021年-2027年）

Global Chronic Myeloid Leukemia (CML) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4014 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、慢性骨髄性白血病（CML）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、化学療法、放射線療法、脾臓摘出術、幹細胞移植）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米...

世界の慢性リンパ性白血病治療薬市場規模・現状・予測（2021年-2027年）

Global Chronic Lymphocytic Leukemia Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4012 2021年6月 120Pages
QYResearch社発行の本調査レポートでは、慢性リンパ性白血病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、点滴薬、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界のプレリキサフォル市場規模・現状・予測（2021年-2027年）

Global Plerixafor Market Size, Status and Forecast 2021-2027
QFJ1-5955 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、プレリキサフォルの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（24MG / 1.2ML、タイプII）、用途別市場規模（非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者）、主要地域別市場規模...

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界のバレニクリン市場規模・現状・予測（2021年-2027年）

Global Varenicline Market Size, Status and Forecast 2021-2027
QFJ1-6060 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、バレニクリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（0.5mg錠、1mg錠）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界のシムリン（プラムリンチド）市場規模・現状・予測（2021年-2027年）

Global Symlin (pramlintide) Market Size, Status and Forecast 2021-2027
QFJ1-6028 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、シムリン（プラムリンチド）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1.5mlペンインジェクター、2.7mlペンインジェクター）、用途別市場規模（I型糖尿病、II型糖尿病）、主要地域別市場規模（...

世界の腫瘍血液検査市場規模・現状・予測（2021年-2027年）

Global Oncology Blood Testing Market Size, Status and Forecast 2021-2027
QFJ1-4605 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、腫瘍血液検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、乳がん、結腸直腸がん、前立腺がん、胃がん、その）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、ア...

世界の慢性歯肉口内炎治療市場規模・現状・予測（2021年-2027年） Chronic gingivostomatitis is a common infection of mouth and gums, leading to drooling and swelling. Sometimes lesions in the mouth resembles the canker sores. This infection is common among children. Market Analysis and Insights: Global Chronic Gingivostomatitis Treatment Market The global Chronic …
世界の慢性創傷ケア市場規模・現状・予測（2021年-2027年） Chronic wound management varies based on the wound location and characteristics. No single approach can be applied to all wounds Market Analysis and Insights: Global Chronic Wound Care Market The global Chronic Wound Care market size is projected to reach US$ XX million by 2027, from US$ XX million …
世界の非ホジキンリンパ腫＆慢性リンパ腫治療市場規模・現状・予測（2021年-2027年） Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of lymphocytes at multiple stages of maturation. There are approximately 30 types of NHLs with varying pathological, clinical, and genetic features. Chronic Lympho…
世界の慢性骨髄性白血病（CML）治療市場規模・現状・予測（2021年-2027年） Chronic myeloid leukaemia (CML) is a type cancer that affects the blood and bone marrow. Market Analysis and Insights: Global Chronic Myeloid Leukemia (CML) Treatment Market The global Chronic Myeloid Leukemia (CML) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX mil…
世界の慢性リンパ性白血病治療薬市場規模・現状・予測（2021年-2027年） Chronic Lymphocytic Leukemia (CLL) is a type of hematological malignancy marked by excessive proliferation of abnormal white blood cells. CLL predominantly affects the B-cell lymphocytes which are involved in the production of antibodies to fight against infections and foreign antigens. Rising incid…